2.9300
-0.1700
(-5.48%)
As of 12:30:31 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -1.06 | -0.76 | -3.17 | -0.56 |
| Low Estimate | -1.06 | -0.76 | -3.17 | -0.56 |
| High Estimate | -1.06 | -0.76 | -3.17 | -0.56 |
| Year Ago EPS | -- | -- | -0.1 | -3.17 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | 1.48M | 1.83M | 7.61M | 7.27M |
| Low Estimate | 792k | 924k | 3.83M | 6.86M |
| High Estimate | 2.17M | 2.73M | 11.4M | 7.69M |
| Year Ago Sales | 6.86M | 5.39M | 28.94M | 7.61M |
| Sales Growth (year/est) | -78.40% | -66.12% | -73.69% | -4.46% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -11.6 | -5.6 | -4.4 | 0 |
| EPS Actual | 0 | 0 | 0 | -- |
| Difference | 11.6 | 5.6 | 4.4 | -- |
| Surprise % | 100.00% | 100.00% | 100.00% | -- |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -1.06 | -0.76 | -3.17 | -0.56 |
| 7 Days Ago | -1.2 | -1.2 | -4.4 | -0.02 |
| 30 Days Ago | -1.2 | -1.2 | -4.4 | -0.02 |
| 60 Days Ago | -1.2 | -1.2 | -4.4 | -0.02 |
| 90 Days Ago | -1.2 | -1.2 | -4.4 | -0.02 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 1 | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BLRX | -- | -- | -2,962.80% | 82.33% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Downgrade | Jones Trading: Buy to Hold | 4/2/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/31/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/25/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/6/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/3/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/29/2024 |
Related Tickers
BCLI Brainstorm Cell Therapeutics Inc.
1.1850
-2.07%
AIM AIM ImmunoTech Inc.
0.1164
-3.80%
OMER Omeros Corporation
7.34
-8.36%
PLX Protalix BioTherapeutics, Inc.
2.5350
-2.12%
DARE Daré Bioscience, Inc.
2.9150
+0.17%
EVAX Evaxion Biotech A/S
1.6664
-1.40%
NBTX Nanobiotix S.A.
3.3036
+1.34%
PTN Palatin Technologies, Inc.
0.5386
+0.07%
LPTX Leap Therapeutics, Inc.
0.3165
-6.91%
CRIS Curis, Inc.
1.3600
-8.11%